[HTML][HTML] Arterial stiffness: A brief review

JP Tsai, BG Hsu - Tzu chi medical journal, 2021 - journals.lww.com
Apart from the result of multiple diseases as well as aging, arterial stiffness (AS) predicts
cardiovascular disease (CVD), especially in patients with chronic kidney disease (CKD) …

[HTML][HTML] Gender-related differences in chronic kidney disease-associated vascular calcification risk and potential risk mediators: a scoping review

PY Wu, SY Lee, KV Chang, CT Chao, JW Huang - Healthcare, 2021 - mdpi.com
Vascular calcification (VC) involves the deposition of calcium apatite in vascular intima or
media. Individuals of advanced age, having diabetes mellitus or chronic kidney disease …

Arterial Stiffness and the Canonical WNT/β-catenin Pathway

A Vallée - Current Hypertension Reports, 2022 - Springer
Abstract Purpose of Review Arterial stiffness (AS) was mainly associated with cardiovascular
morbidity and mortality in a hypertensive patient. Some risk factors contribute to the …

[HTML][HTML] Association between plasma fibulin-1 and brachial-ankle pulse wave velocity in arterial stiffness

M Luo, D Yan, X Liang, Y Huang, P Luo… - Frontiers in …, 2022 - frontiersin.org
Arterial stiffness forms the basis of cardiovascular diseases (CVD) and is also an
independent predictor of CVD risk. Early detection and intervention of arterial stiffness are …

[HTML][HTML] Serum osteoprotegerin and carotid intima-media thickness are related to high arterial stiffness in heart failure with reduced ejection fraction

L Fehervari, A Frigy, L Kocsis, IA Szabo, TM Szabo… - Diagnostics, 2021 - mdpi.com
Arterial stiffness (AS) is a complex vascular phenomenon with consequences for central
hemodynamics and left-ventricular performance. Circulating biomarkers have been …

骨保护素参与高磷诱导大鼠血管平滑肌细胞钙化调节的机制初探.

窦建新, 孙丽萍, 刘长山, 王秀军… - Tianjin Medical …, 2020 - search.ebscohost.com
目的以β-磷酸甘油诱导大鼠血管平滑肌细胞(VSMC) 钙化模型为研究对象, 初步探讨骨保护素(
OPG) 干预对VSMC 钙化的影响及机制. 方法体外分离培养大鼠主动脉VSMC. PBS 为对照组 …

[HTML][HTML] Association of circulating osteoprotegerin level with blood pressure variability in patients with chronic kidney disease

SH Suh, TR Oh, HS Choi, CS Kim, KH Oh… - Journal of Clinical …, 2021 - mdpi.com
Circulating osteoprotegerin (OPG) is a biomarker for cardiovascular complications that are
closely related to chronic kidney disease (CKD). To investigate the association between …

Low serum 3‐methyl histidine level is associated with aortic stiffness in maintenance hemodialysis patients

YC Chang, CH Wang, YH Lai, YL Lin… - Therapeutic …, 2022 - Wiley Online Library
Methylhistidine (3MH) is an indicator of muscle catabolism. Subclinical protein malnutrition
is an independent predictor of aortic stiffness (AS). We aimed to study the relationship …

[PDF][PDF] Serum Osteoprotegerin and Carotid Intima-Media Thickness Are Related to High Arterial Stiffness in Heart Failure with Reduced Ejection Fraction. Diagnostics …

L Fehérvári, A Frigy, L Kocsis, IA Szabó, TM Szabo… - 2021 - academia.edu
Arterial stiffness (AS) is a complex vascular phenomenon with consequences for central
hemodynamics and left-ventricular performance. Circulating biomarkers have been …

Osteoprotegerin and Vascular Dysfunction in Patients With Stage 3 Chronic Kidney Disease and Those Without Renal Dysfunction: a Case-control Study (Nefrovasc …

TO Matos, PVO Vitorino, R Orlow, ÁO Melo, DS Amorim… - 2023 - researchsquare.com
Background: Osteoprotegerin (OPG) is a marker of vascular calcification and cardiovascular
(CV) risk in patients with chronic kidney disease (CKD). The study aimed to compare OPG …